Keywords: AD, atopic dermatitis; AU, alopecia universalis; IFN, interferon; IL, interleukin; ILCs, innate lymphoid cells; JAK inhibitor; Th2, T-helper type 2 cells; alopecia universalis; atopic dermatitis; tofacitinib.